New mRNA jab for urinary infections in the pipeline for Australia

TOTT News

2 years ago

$1.8 million in funding for UTI mRNA ‘treatments’.

NEW MRNA JAB

The mRNA ‘revolution’ is set to continue, with a new jab being rolled out for urinary tract infections (UTI).

The University of Technology Sydney will receive $1.8 million from the MRFF’s Global Health Initiative to develop an mRNA vaccine with hopes of ‘preventing recurrent UTIs’, it has been announced.

Approximately 250,000 Australians develop a UTI each year, with more than 1 in 2 women and 1 in 20 men are likely to have a UTI in their lifetime. But we’ll get into why these numbers aren’t so scary later.

Escherichia coli – or E. coli bacteria – is currently treatable with antibiotics, but now, the ‘experts’ are emerging to say that some strains are already resistant to them, and as more become resistant, “new forms of treatment will be needed”. Those new ‘forms’ will be the experimental mRNA technology.

The researchers of the project say the funding (your taxpayer dollars) will lead to clinical trials in the next three years for people who suffer very frequent UTIs, including patients who use catheters.

Branwen Morgan, Lead of the Minimising Antimicrobial Resistance Mission at CSIRO, said as the rates of ‘antimicrobial resistance continue to rise’, UTIs are ‘becoming harder to treat and often recur’.

So, let’s turn to the most unknown genome alteration therapy introduced to man, mRNA!

mRNA technology was selected, they say, due to “…its potential advantages in eliciting immune responses against bacteria that have demonstrated resilience to conventional vaccine strategies”.

It’s funny how normal vaccines have suddenly, officially, become utterly useless. What about the decades of intergenerational propaganda telling people they were the ‘frontier’ of science?

“This is a new approach to bacterial vaccine development that we believe will save time and money by creating a streamlined and efficient workflow,” Morgan said.

“Vaccines for drug-resistant pathogens are one of the Minimising Antimicrobial Resistance (AMR) Mission’s priorities — not just in humans but in animals too. Many of the considerations for the design and manufacture of human and animal vaccines are the same.“

Oh, they sure are. And if people knew what the COVID jabs were based off.. man.

“More broadly, we have an aim to accelerate the development and implementation of AMR solutions as well as grow public and private investment into this research space because time is running out and the R&D pipeline for new antibiotics will not keep pace with clinical need,” Morgan continued.

The move is part of a larger push by the federal government to fund research projects aimed at finding mRNA vaccines to prevent cancer and other diseases too.

The Medical Research Future Fund’s National Critical Research Infrastructure Initiative seeks to “…build out the infrastructure required to safely develop, test and evaluate mRNA therapies and vaccines”.

The MRFF is a $22 billion long-term federal government investment supporting Australian health and medical research, now entering it’s third decade of development.

It is managed by the Future Fund, an independently managed sovereign wealth fund established in 2006 to strengthen the Australian Government’s long-term financial position during a period when an ageing population is likely to place significant pressure on the Commonwealth’s finances.

As of 31 December 2023, the fund has $272.3 billion in assets under management.

It’s funny how completely treatable diseases are now ‘needing’ mRNA and advanced genome technologies as part of sophisticated biopharma funding schemes.

‘Natural immunity’ and ‘antibiotics’ are becoming things of the past..

It seems they have completely changed their tone from even a few years ago..

WHY THE SHIFT?

George Orwell summed it up perfectly in his dystopian novel, with the history being re-written (false ration increases come to mind) and the changing of messages (we were always at war with Eurasia).

Just a few years ago, UTIs — which despite having large numbers of patients is actually one of the more treatable infections one can have — was seen as something mundane and not in need of ‘new solutions’.

One randomised study by Harvard in 2021, for example, found that ‘less is more’ when treating UTIs.

Their study involved two groups of men with UTI symptoms (average age 69). Half of the men took antibiotics for 14 days, while the other half took them for seven days.

Both durations had similar outcomes. The seven-day treatment had an average 92.5% success rate, while the 14-day treatment had an average 90.3% rate. Both groups also had a similar percentage of UTI recurrence (9.9% for the seven-day treatment and 12.9% for the 14-day treatment).

In essence, it was found that you didn’t even need that much in terms of antibiotics to get good results.

Why all of a sudden the massive change in tone and direction for treatment?

Anyone with half a brain knows the answer to that.

Just take a look at the widespread conflicts of interests that plague the medical world.

“Widespread”: Australian medical researchers fail to declare conflicts of interest

A hundred years of intense propaganda promoting the idea that ‘diseases are everywhere’, and each disease is caused by a single germ, which must be killed by a medical drug.